ESC 365 - Advantages of prophylactic versus conventionally scheduled heart failure treatment in doxorubicin induced cardiomyopathy

HFA Premium Access

Advantages of prophylactic versus conventionally scheduled heart failure treatment in doxorubicin induced cardiomyopathy

Session: Poster Session 3 - Basic Science - Basic Science - Cardiac Diseases

Topic: Cardiac Diseases

Speaker: Miss M. Lodi (Debrecen, HU)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Miss Maria Lodi

University of Debrecen, Debrecen (Hungary)

0 follower

28 more presentations in this session

Hypertrophic cardiomyopathy: variable expression of mutant and wildtype protein from cell-to-cell leading to contractile imbalance - a possible trigger for pathogenesis

Speaker: Doctor T. Kraft (Hannover, DE)

Mitigation of anthracycline cardiotoxicity through liposomal formulation is mediated by activation of interferon-inducible genes in pigs

Speaker: Doctor J. Winkler (Vienna, AT)

Shock wave therapy improves cardiac function in a model of chronic ischemic heart failure-evidence for a mechanism involving VEGF signaling and the extracellular matrix

Speaker: Associate Professor J. Holfeld (Innsbruck, AT)

Non-hypertrophic and hypertrophic human cardiomyocytes secrete unprocessed ANP and BNP precursors (proANP/proBNP) and exhibit a similar efficiency in their processing

Speaker: Doctor A. Semenov (Turku, FI)

The effect of free fatty acids on endogenous angiotensin converting enzyme inhibition

Speaker: Doctor M. Fagyas (Debrecen, HU)

Access the full session

Poster Session 3 - Basic Science - Basic Science - Cardiac Diseases

Speakers: Miss M. Lodi, Doctor T. Kraft, Doctor J. Winkler, Associate Professor J. Holfeld, Doctor A. Semenov...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources